Michael Sabranski

Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients

Christian Hoffmann, Tanya Welz, Michael Sabranski et al. · HIV Medicine · 2016 · 272 citations · Full text

Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease

Christian Hoffmann, Holger Schmid, Markus Müller et al. · Blood · 2011 · 89 citations · Full text

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Man‐Fung Yuen, Tarik Asselah, Ira M. Jacobson et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 64 citations

Ide Analogues, Viral Hepatitis, Medicine +10

Treatment of AIDS-related lymphomas

Christoph Wyen, Björn‐Erik Ole Jensen, Marcus Hentrich et al. · AIDS · 2011 · 32 citations

Short-Term Neuropsychiatric Tolerability of Bictegravir Combined with Emtricitabine/Tenofovir Alafenamide in Clinical Practice

Christian Hoffmann, Knud Schewe, Stefan Fenske et al. · Antiviral Therapy · 2019 · 25 citations